The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Thyroid Cancer Testing Market Research Report 2025
Synopsis
Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones.
The global Thyroid Cancer Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technological advancements are expected to boost the market of thyroid cancer testing.
This report aims to provide a comprehensive presentation of the global market for Thyroid Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Cancer Testing.
Report Scope
The Thyroid Cancer Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Cancer Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Cancer Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Thermo Fisher Scientific
Siemens
Bio Rad Laboratories
GE Healthcare
Illumina
Koninklijke Philips
Canon Medical Systems
Agilent Technologies
Segment by Type
Imaging Tests
Blood Tests
Biopsy Tests
Other
Segment by Application
Hospital Associated Labs
Independent Diagnostic Labs
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Cancer Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones.
The global Thyroid Cancer Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technological advancements are expected to boost the market of thyroid cancer testing.
This report aims to provide a comprehensive presentation of the global market for Thyroid Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Cancer Testing.
Report Scope
The Thyroid Cancer Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Cancer Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Cancer Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Thermo Fisher Scientific
Siemens
Bio Rad Laboratories
GE Healthcare
Illumina
Koninklijke Philips
Canon Medical Systems
Agilent Technologies
Segment by Type
Imaging Tests
Blood Tests
Biopsy Tests
Other
Segment by Application
Hospital Associated Labs
Independent Diagnostic Labs
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Cancer Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Cancer Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imaging Tests
1.2.3 Blood Tests
1.2.4 Biopsy Tests
1.2.5 Other
1.3 Market by Application
1.3.1 Global Thyroid Cancer Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Associated Labs
1.3.3 Independent Diagnostic Labs
1.3.4 Diagnostic Imaging Centers
1.3.5 Cancer Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thyroid Cancer Testing Market Perspective (2019-2030)
2.2 Thyroid Cancer Testing Growth Trends by Region
2.2.1 Global Thyroid Cancer Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Thyroid Cancer Testing Historic Market Size by Region (2019-2024)
2.2.3 Thyroid Cancer Testing Forecasted Market Size by Region (2025-2030)
2.3 Thyroid Cancer Testing Market Dynamics
2.3.1 Thyroid Cancer Testing Industry Trends
2.3.2 Thyroid Cancer Testing Market Drivers
2.3.3 Thyroid Cancer Testing Market Challenges
2.3.4 Thyroid Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thyroid Cancer Testing Players by Revenue
3.1.1 Global Top Thyroid Cancer Testing Players by Revenue (2019-2024)
3.1.2 Global Thyroid Cancer Testing Revenue Market Share by Players (2019-2024)
3.2 Global Thyroid Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thyroid Cancer Testing Revenue
3.4 Global Thyroid Cancer Testing Market Concentration Ratio
3.4.1 Global Thyroid Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Cancer Testing Revenue in 2023
3.5 Thyroid Cancer Testing Key Players Head office and Area Served
3.6 Key Players Thyroid Cancer Testing Product Solution and Service
3.7 Date of Enter into Thyroid Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thyroid Cancer Testing Breakdown Data by Type
4.1 Global Thyroid Cancer Testing Historic Market Size by Type (2019-2024)
4.2 Global Thyroid Cancer Testing Forecasted Market Size by Type (2025-2030)
5 Thyroid Cancer Testing Breakdown Data by Application
5.1 Global Thyroid Cancer Testing Historic Market Size by Application (2019-2024)
5.2 Global Thyroid Cancer Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Thyroid Cancer Testing Market Size (2019-2030)
6.2 North America Thyroid Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Thyroid Cancer Testing Market Size by Country (2019-2024)
6.4 North America Thyroid Cancer Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thyroid Cancer Testing Market Size (2019-2030)
7.2 Europe Thyroid Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Thyroid Cancer Testing Market Size by Country (2019-2024)
7.4 Europe Thyroid Cancer Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Cancer Testing Market Size (2019-2030)
8.2 Asia-Pacific Thyroid Cancer Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Thyroid Cancer Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Thyroid Cancer Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thyroid Cancer Testing Market Size (2019-2030)
9.2 Latin America Thyroid Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Thyroid Cancer Testing Market Size by Country (2019-2024)
9.4 Latin America Thyroid Cancer Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Cancer Testing Market Size (2019-2030)
10.2 Middle East & Africa Thyroid Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Thyroid Cancer Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Thyroid Cancer Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Thyroid Cancer Testing Introduction
11.1.4 Abbott Laboratories Revenue in Thyroid Cancer Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Thyroid Cancer Testing Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Thyroid Cancer Testing Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Thyroid Cancer Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Thyroid Cancer Testing Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Siemens
11.4.1 Siemens Company Detail
11.4.2 Siemens Business Overview
11.4.3 Siemens Thyroid Cancer Testing Introduction
11.4.4 Siemens Revenue in Thyroid Cancer Testing Business (2019-2024)
11.4.5 Siemens Recent Development
11.5 Bio Rad Laboratories
11.5.1 Bio Rad Laboratories Company Detail
11.5.2 Bio Rad Laboratories Business Overview
11.5.3 Bio Rad Laboratories Thyroid Cancer Testing Introduction
11.5.4 Bio Rad Laboratories Revenue in Thyroid Cancer Testing Business (2019-2024)
11.5.5 Bio Rad Laboratories Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Thyroid Cancer Testing Introduction
11.6.4 GE Healthcare Revenue in Thyroid Cancer Testing Business (2019-2024)
11.6.5 GE Healthcare Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Thyroid Cancer Testing Introduction
11.7.4 Illumina Revenue in Thyroid Cancer Testing Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Detail
11.8.2 Koninklijke Philips Business Overview
11.8.3 Koninklijke Philips Thyroid Cancer Testing Introduction
11.8.4 Koninklijke Philips Revenue in Thyroid Cancer Testing Business (2019-2024)
11.8.5 Koninklijke Philips Recent Development
11.9 Canon Medical Systems
11.9.1 Canon Medical Systems Company Detail
11.9.2 Canon Medical Systems Business Overview
11.9.3 Canon Medical Systems Thyroid Cancer Testing Introduction
11.9.4 Canon Medical Systems Revenue in Thyroid Cancer Testing Business (2019-2024)
11.9.5 Canon Medical Systems Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Detail
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Thyroid Cancer Testing Introduction
11.10.4 Agilent Technologies Revenue in Thyroid Cancer Testing Business (2019-2024)
11.10.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
